Clinical Practice Guidelines (CPG)

  • Management of Heart Failure 2019 (4th Edition)

    Since the last CPG in 2014 the treatment modalities for the management of HF has expanded extensively. There have been many significant developments in the use of drugs and devices. These guideline-changing data have been incorporated into this CPG, taking into account our local health resources.

     

    (Click to read more)

  • CPG Slides Summary - Management of Heart Failure 2019 (4th Edition)

    Slides set is available for download!

    (Click to download in PDF)

  • CPG Slides Summary - STEMI 2019 (4th Edition)

    STEMI 2019 (4th Edition) - slides set is available for download!

    (Click to download in PDF)

  • CPG Slides Summary

    Stable Coronary Artery Disease 2018 (2nd Edition) slides set is available for download!

    (Click to download in PDF)

  • CPG Slides Summary

    Primary & Secondary Prevention of Cardiovascular Disease 2017 (1st Edition) slides set is available for download!

    (Click to download in PDF)

  • CPG Slides Summary

    Management of Dyslipidaemia 2017 (5th Edition) slides set is available for download!

    (Click to download in PDF)

  • Stable Coronary Artery Disease 2018 (2nd Edition)

    The previous clinical practice guidelines for the management of stable angina were issued in 2010. Since then, there have been advances in both diagnostic and therapeutic strategies in the management of this progressive disease. Therefore, it is timely for the publication of this CPG, with a title that is now evolved from stable angina to that of stable coronary artery disease (SCAD).

     

    (Click to read more)

  • Primary & Secondary Prevention of Cardiovascular Disease 2017

    Cardiovascular Diseases (CVD) has been the leading cause of death in Malaysian since the early 1980s. The National Burden of Disease Study in early 2000s showed that coronary artery disease (CAD) and cerebrovascular disease (CVA) are the top two causes of death for both men and women. What is of concern is that the age of onset of CVD in Malaysia is younger compared to our neighbors and some western nations.

     

    (Click to read more)

  • Management of Dyslipidaemia 2017 (5th Edition)

    Dyslipidaemia remains a significant problem in Malaysia, with the National Health and Morbidity survey in 2015 reporting an estimated 47% of the adult population having hypercholesterolaemia. In the main, dyslipidaemia is asymptomatic but its associations with serious vascular conditions such as acute myocardial infarction and stroke is well known.

    (Click to read more)

  • Prevention, Diagnosis & Management of Infective Endocarditis 2017

    Infective endocarditis (IE) is an uncommon and potentially lethal infection affecting patients at risk. Despite advances in medicine, IE still causes significant morbidity and mortality. This is due to the changing epidemiology of the disease, the wide spectrum of presentation extending from the neonate to the elderly, diagnostic difficulties, delayed surgical interventions and embolic complications.

    (Click to read more)